Anlon Healthcare Ltd Share Price

Pharmaceuticals - Indian - Bulk Drugs & Formln M/SNSE
₹25.17
+0.20+0.80% (1D)
As on 20 Nov 2026 at 15:57
As of 20 Nov 2026 at 15:57, Anlon Healthcare Ltd is trading at ₹25.17. The 52-week range stands at ₹10.37–₹37.24, with a market cap of ₹1.34 thousand crore. At a P/E of 48.35 and a dividend yield of 0.00%, it is a small-cap stock in the Pharmaceuticals sector.

AHCL Price Chart

Market Cap
₹1.34K Cr
PE Ratio
48.35
ROCE
16.70%

Anlon Healthcare Ltd Performance

Anlon Healthcare Ltd Fundamentals

Know More
Market Cap₹1.34K Cr
ROE12.49%
P/E Ratio (TTM)48.35
EPS (TTM)₹0.52
P/B Ratio6.01
Dividend Yield0.00%
Industry P/E91.72
Book Value₹4.19
Debt to Equity0.26
Face Value₹2

Anlon Healthcare Ltd Shareholding Pattern

Know More
Promoter52.7%
Foreign Institutions1%
Mutual Funds0%
Domestic Institutions0.1%
Public46.3%

Anlon Healthcare Ltd Financial Statements

Know More
No data for this view.

Anlon Healthcare Ltd Peer Comparison

Know More
StocksLTP(₹)Market Cap(Cr)52 Week Low-High(₹)
Sun Pharmaceutical Industries Ltd
₹1,885.10
-14.90(-0.78%)
4,52,298.61,583.7 - 2,046.9
Torrent Pharmaceuticals Ltd
₹4,698.80
87.80(+1.90%)
1,78,727.33,672.3 - 5,250.0
Dr Reddys Laboratories Ltd
₹1,390.50
-10.40(-0.74%)
1,16,144.51,101.0 - 1,414.9
Cipla Ltd
₹1,414.95
-3.55(-0.25%)
1,14,312.11,165.7 - 1,539.7
Lupin Ltd
₹2,010.00
11.20(+0.56%)
91,915.91,892.9 - 2,529.5

About Anlon Healthcare

Anlon Healthcare Limited was originally incorporated as 'Anlon Ventures Private Limited', dated November 19, 2013 with the RoC. The Company changed the name to 'Anlon Healthcare Private Limited' dated May 27, 2015 issued by the RoC and further beame a Public Company named 'Anlon Healthcare Limited' dated September 2, 2024. ANLON an ideal API partner is research-driven company engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Bulk Drugs and advanced pharmaceutical intermediates. It specialize in manufacturing of high-purity pharmaceutical intermediates used as key starting materials for APIs and finished dosage formulations. It is among the few Indian manufacturers of products such as Loxoprofen Sodium Dihydrate, Ketoprofen, and Dexketoprofen Trometamol, which are widely used in pain management and anti-inflammatory therapies which comply with the regulatory requirements of leading health authorities such as FDA, PMDA, KFDA, cGMP, WHO-GMP. In addition to manufacturing of Pharma Intermediate and APIs in accordance with various domestic and international standards, the Company has recently started undertaking custom manufacturing services for complex or novel chemical compounds. The Company started commercial production of Pharma Intermediate and API in 2018. It work out manufacturing activities at Rajkot, Gujarat, which comprise of two separate manufacturing blocks for manufacturing of Pharmaceutical Intermediate and APIs respectively with an aggregate installed production capacity of 400 MTPA. The Company launched the Initial Public Offering of 1,33,00,000 equity shares having the face value of Rs 10, by raising funds aggregating to Rs 121.03 Cr via fresh issue on 29 August, 2025. The Company acquired 67.48% equity shareholding in Apiqo Organics Private Limited and become subsidiary of the company w.e.f. January 09, 2026. It further acquired 56.67% equity shareholding in Bizotic Life Science Private Limited and become subsidiary of the company w.e.f. March 20, 2026.

Parent Organisation—
Founded2013
Managing DirectorPunitkumar R Rasadia
NSE SymbolAHCL

Anlon Healthcare Ltd Resistance and Support levels

R326.15R225.78R125.55S124.81S224.58S324.2125.17

Anlon Healthcare Ltd Technicals

Current Price
₹25.17 ₹0.20 (+0.80%)
Bearish
7
Bullish
5
  • 20 Day4.0%
  • 50 Day0.7%
  • 100 Day13.6%
  • 200 Day32.9%

Anlon Healthcare Ltd Latest News

View More
19 OCT 2026 | Monday
Anlon Healthcare reported to BSE and NSE via certificate, using Kfin Technologies
29 SEPT 2026 | Tuesday
Anlon Healthcare plans to discuss expansion and potential fundraising at October board meeting
28 SEPT 2026 | Monday
Anlon Healthcare closes securities trading window ahead of financial results declaration
15 SEPT 2026 | Tuesday
Brickwork Ratings assigned a BBB/Stable rating to Anlon Healthcare's long-term facilities totaling Rs. 23.60 crore
13 AUG 2026 | Thursday
Anlon Healthcare to acquire 28.33% stake in subsidiary Anlon Medicos for Rs 500 Crore
13 AUG 2026 | Thursday
Anlon Healthcare’s Rs 5000 Lakhs transactions with a subsidiary face scrutiny due to financial concerns
13 AUG 2026 | Thursday
Anlon Healthcare to issue shares in a swap with Apiqo and Bizotic entities
11 AUG 2026 | Tuesday
Anlon Healthcare Limited delays board meeting to August 13 due to administrative reasons
08 AUG 2026 | Saturday
Anlon Healthcare to issue shares in a swap with Apiqo and Bizotic, per SEC filings
06 AUG 2026 | Thursday
Anlon Healthcare to approve financials and consider director reappointment on August 11

2026

Quarterly ResultRelease dateCheck Latest financial
Board MeetingAnnounced
Board MeetingAnnounced
Quarterly ResultRelease dateCheck Latest financial
Board MeetingAnnounced
Quarterly ResultRelease dateCheck Latest financial
Board MeetingAnnounced
Board MeetingAnnounced
Board MeetingAnnounced
Quarterly ResultRelease dateCheck Latest financial

Frequently asked questions

The share price of Anlon Healthcare Ltd is ₹25.17 as of 20 Nov 2026 at 15:57.

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now